Data di Pubblicazione:
2020
Abstract:
The effect of vericiguat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced ejection fraction who had recently been hospitalized or had received intravenous diuretic therapy is unclear.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Administration, Oral; Aged; Cardiovascular Diseases; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Heterocyclic Compounds, 2-Ring; Hospitalization; Humans; Hypotension; Incidence; Male; Middle Aged; Pyrimidines; Soluble Guanylyl Cyclase; Stroke Volume; Syncope; Ventricular Dysfunction, Left
Elenco autori:
Armstrong, Paul W; Pieske, Burkert; Anstrom, Kevin J; Ezekowitz, Justin; Hernandez, Adrian F; Butler, Javed; Lam, Carolyn S P; Ponikowski, Piotr; Voors, Adriaan A; Jia, Gang; Mcnulty, Steven E; Patel, Mahesh J; Roessig, Lothar; Koglin, Joerg; O'Connor, ; Christopher, M; Nodari, S
Link alla scheda completa:
Pubblicato in: